- Home
- OBIO vs CMCM Comparison
OBIO vs CMCM Comparison
Compare OBIO & CMCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OBIO
- CMCM
- Stock Information
- Founded
- OBIO 2017
- CMCM 2009
- Country
- OBIO United States
- CMCM China
- Employees
- OBIO N/A
- CMCM N/A
- Industry
- OBIO Medicinal Chemicals and Botanical Products
- CMCM Computer Software: Prepackaged Software
- Sector
- OBIO Health Care
- CMCM Technology
- Exchange
- OBIO Nasdaq
- CMCM Nasdaq
- Market Cap
- OBIO 151.3M
- CMCM 127.6M
- IPO Year
- OBIO N/A
- CMCM 2014
- Fundamental
- Price
- OBIO $2.65
- CMCM $3.80
- Analyst Decision
- OBIO Strong Buy
- CMCM
- Analyst Count
- OBIO 5
- CMCM 0
- Target Price
- OBIO $14.20
- CMCM N/A
- AVG Volume (30 Days)
- OBIO 959.6K
- CMCM 15.7K
- Earning Date
- OBIO 05-16-2025
- CMCM 06-06-2025
- Dividend Yield
- OBIO N/A
- CMCM N/A
- EPS Growth
- OBIO N/A
- CMCM N/A
- EPS
- OBIO N/A
- CMCM N/A
- Revenue
- OBIO $2,638,000.00
- CMCM $110,544,725.00
- Revenue This Year
- OBIO $13.87
- CMCM $14.27
- Revenue Next Year
- OBIO $32.19
- CMCM $39.26
- P/E Ratio
- OBIO N/A
- CMCM N/A
- Revenue Growth
- OBIO N/A
- CMCM 20.52
- 52 Week Low
- OBIO $2.43
- CMCM $3.02
- 52 Week High
- OBIO $8.87
- CMCM $6.78
- Technical
- Relative Strength Index (RSI)
- OBIO 43.61
- CMCM 45.39
- Support Level
- OBIO $2.37
- CMCM $3.65
- Resistance Level
- OBIO $2.99
- CMCM $3.90
- Average True Range (ATR)
- OBIO 0.33
- CMCM 0.14
- MACD
- OBIO 0.05
- CMCM 0.05
- Stochastic Oscillator
- OBIO 32.18
- CMCM 42.86
About OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the global commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.
About CMCM Cheetah Mobile Inc. each representing fifty (50)
Cheetah Mobile Inc along with its subsidiaries provides comprehensive products and services on PCs and mobile devices. It generates revenue from utility-related business, including advertising services and premium membership services. It also provides multi-cloud management platform and overseas advertising agency service. The company operates in two segments: Internet business, and AI and others. The firm's majority of the revenue is derived from the internet business segment that provides mobile advertising services to advertising customers, as well as selling advertisements and referring user traffic on its mobile and PC platforms. Geographically, it derives the majority of its revenue from the PRC and the rest from Hong Kong, Japan, and the rest of the world.